Whether the COMT gene directly supports gut health is not well established. COMT (catechol-O-methyltransferase) primarily degrades catecholamines like dopamine and adrenaline, and also metabolizes estrogens. Some research suggests a role in the gut–brain axis: COMT is expressed in enteric neurons and may influence gut motility and barrier function. However, most evidence comes from animal models or in vitro studies; human data are limited and inconsistent. A few GWAS have linked COMT variants (e.g., Val158Met) to irritable bowel syndrome (IBS), but effect sizes are small and replication is poor. Consumer DNA tests that report COMT SNPs cannot provide actionable insights for gut health. The evidence level is mechanistic/unclear. No clinical guidelines recommend COMT genotyping for digestive issues. If you have persistent gut symptoms, see a healthcare professional rather than relying on a single gene test. In short, COMT has a plausible but unproven connection to gut health; current evidence does not support using it for dietary or lifestyle decisions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-349a0699880bdbe89325a0dd